Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Sabine C. Iben, MD, is Assistant Professor in Cleveland Clinic Children’s Hospital Department of Neonatology and the Neonatal Director of the Fetal Care Center.
Dr. Iben earned her medical degree from Fakultät für Klinische Medizin der Universität Heidelberg, Germany. Her post-graduate training includes a pediatric residency at University Hospital of Missouri, Columbia and a fellowship in neonatal-perinatal medicine at Rainbow Babies and Children’s Hospital in Cleveland, Ohio. She completed additional training in neonatal-perinatal medicine and pediatric critical care at University Hospital in Heidelberg, Germany.
Dr. Iben is board certified in both general pediatrics and neonatal-perinatal medicine. She is an instructor for the Neonatal Resuscitation Program and also holds certifications in pediatric advanced life support and advanced cardiovascular life support from the American Heart Association.
Dr. Iben is a member of several professional organizations, including the American Academy of Pediatrics and the Midwestern Society of Pediatric Research.
Dr. Iben has published multiple research articles in peer-reviewed journals, as well as having contributed abstracts at a number of professional association meetings on ventilator induced lung injury. She has been invited to lecture and present at local, national and global institutions on topics such as protein metabolism in premature infants, gastro intestinal obstructions, and steroids in neonatology, among others.
Her specialty interests include complex congenital malformations, chronic lung disease of prematurity, and neonatal nutrition.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 11/4/2014, Dr. Iben has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.